North America Startup Funding Rounds
Startups raising capital across North America. Compare the businesses, funding stages and investors active in the region.
- Rounds
- 2,307 Jan 1 – Oct 24, 2026
- Disclosed funding
- $211.5B 1913 disclosed amounts
- Median round
- $23M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| S Provides AI-driven cloud infrastructure optimization for enterprises | $3M | Seed | Enterprise software | United States | Investors | |
| K KosmosCompany profile Correlates signals across IT tools to surface root-cause intelligence for enterprise support and engineering teams Correlates signals across IT tools to surface root-cause intelligence for enterprise support and engineering teams | $5M | Seed | AI | United States | Investors | |
 Advanced NanoTherapiesCompany profile Advanced NanoTherapies develops nanoparticle-coated balloons that deliver two drugs locally during vascular procedures, starting with its investigational SirPlux Duo device. Advanced NanoTherapies develops nanoparticle-coated balloons that deliver two drugs locally during vascular procedures, starting with its investigational SirPlux Duo device. | >$31M | Series B | Healthtech | United States | Investors | |
| IS Impulse SpaceCompany profile Builds highly maneuverable orbital transfer vehicles and kick stages for in-space mobility and satellite logistics Builds highly maneuverable orbital transfer vehicles and kick stages for in-space mobility and satellite logistics | $500M | Series DSeries C+ | Space tech | United States | Investors | |
| TB Develops novel therapeutics for glaucoma and retinal diseases | $17M | Series A | Biotech | United States | Investors | |
| C ContralineCompany profile Develops hormonal and non-hormonal male contraceptives for men and couples globally Develops hormonal and non-hormonal male contraceptives for men and couples globally | $92.5M | Series B | Biotech | United States | Investors | |
| S SewerAICompany profile Provides AI software for utilities to inspect, assess, and rehabilitate sewer infrastructure Provides AI software for utilities to inspect, assess, and rehabilitate sewer infrastructure | Undisclosed | StrategicUndisclosed | Enterprise software | United States | Investors | |
| SM Subtle MedicalCompany profile Develops AI-powered medical imaging software to improve workflow efficiency and image quality Develops AI-powered medical imaging software to improve workflow efficiency and image quality | $33M | Growth | Healthtech | United States | Investors | |
| N NovelliaCompany profile Platform that unifies patient health records for individuals and supplies anonymized data to pharma researchers Platform that unifies patient health records for individuals and supplies anonymized data to pharma researchers | $18M | Series A | Healthtech | United States | Investors | |
 NewLimitCompany profile NewLimit develops epigenetic reprogramming medicines designed to restore function in aging cells and treat age-related disease. NewLimit develops epigenetic reprogramming medicines designed to restore function in aging cells and treat age-related disease. | $435M | Series CSeries C+ | Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
BioStack, Tractian, Blacksmith
134rounds3led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
98rounds19led - 3General Catalyst
Tractian, Different, Baba
70rounds7led - 4Alumni Ventures
Maxinsights, Daytona, Chariot Claims
60rounds0led - 5Khosla Ventures
Arda Industries, Tolan
59rounds6led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.